Waning Vaccine Effectiveness Against Influenza-Associated Hospitalizations Among Adults, 2015–2016 to 2018–2019, United States Hospitalized Adult Influenza Vaccine Effectiveness NetworkArticle Published on 2021-08-152023-06-14 Journal: Clinical Infectious Diseases: An Official Publicat [Category] Fulltext, 신종인플루엔자, [키워드] Adults Hospitalization Influenza vaccine effectiveness waning [DOI] 10.1093/cid/ciab045 PMC 바로가기
Does BCG provide long-term protection against SARS-CoV-2 infection? A case–control study in Quebec, CanadaArticle Published on 2021-08-112023-06-16 Journal: Vaccine [Category] MERS, SARS, [키워드] BCG COVID-19 SARS-CoV-2 vaccine effectiveness [DOI] 10.1016/j.vaccine.2021.08.019 PMC 바로가기 [Article Type] Article
Influenza vaccine effectiveness against influenza-associated hospitalization in children in Hong Kong, 2010-2020Article Published on 2021-08-092023-06-24 Journal: Vaccine [Category] 신종인플루엔자, [키워드] Influenza public health vaccine effectiveness [DOI] 10.1016/j.vaccine.2021.07.014
Vaccine effectiveness against SARS-CoV-2 transmission and infections among household and other close contacts of confirmed cases, the Netherlands, February to May 2021Rapid Communication Published on 2021-08-052022-10-31 Journal: Eurosurveillance [Category] COVID-19, MERS, SARS, [키워드] adjusted close contact confirmed cases Contact COVID-19 COVID-19 vaccine Effectiveness estimate household contact household study index case Infection knowledge Netherlands SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 transmission secondary attack rate severe disease the vaccine Transmission vaccine effectiveness [DOI] 10.2807/1560-7917.ES.2021.26.31.2100640 PMC 바로가기 [Article Type] Rapid Communication
BNT162b2 mRNA COVID-19 Vaccine Effectiveness in the Prevention of SARS-CoV-2 Infection: A Preliminary ReportObservational Study Published on 2021-08-022022-10-05 Journal: The Journal of Infectious Diseases [Category] 임상, [키워드] 95% CI 95% confidence interval BNT162b2 mRNA collected COVID-19 documented infection Effectiveness Efficacy evaluate first dose HCW HCWs Health care worker healthcare Healthcare workers Infection mRNA vaccine of BNT162b2 pandemic prevention report SARS-CoV-2 SARS-COV-2 infection second dose Trial university vaccination vaccination schedule Vaccine vaccine effectiveness [DOI] 10.1093/infdis/jiab262 PMC 바로가기 [Article Type] Observational Study
Effects of Prior Season Vaccination on Current Season Vaccine Effectiveness in the United States Flu Vaccine Effectiveness Network, 2012–2013 Through 2017–2018Article Published on 2021-08-012023-06-14 Journal: Clinical Infectious Diseases: An Official Publicat [Category] Fulltext, 신종인플루엔자, [키워드] Influenza prior vaccination repeat vaccination vaccine effectiveness Vaccines [DOI] 10.1093/cid/ciaa706 PMC 바로가기
Influenza Vaccine Effectiveness in Inpatient and Outpatient Settings in the United States, 2015–2018Article Published on 2021-08-012023-06-14 Journal: Clinical Infectious Diseases: An Official Publicat [Category] Fulltext, 신종인플루엔자, [키워드] attenuation Hospitalization Influenza severity vaccine effectiveness [DOI] 10.1093/cid/ciaa407 PMC 바로가기
Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021Rapid Communication Published on 2021-07-222022-10-31 Journal: Eurosurveillance [Category] COVID-19, SARS, [키워드] Complete Control COVID-19 COVID-19 vaccine dose Effectiveness eight Europe European main analysis multicentre multicentre study Older SARS-CoV-2 symptomatic SARS-CoV-2 infection test-negative design vaccinated individuals vaccination vaccine effectiveness [DOI] 10.2807/1560-7917.ES.2021.26.29.2100670 PMC 바로가기 [Article Type] Rapid Communication
Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: interim results of a living systematic review, 1 January to 14 May 2021Rapid Communication Published on 2021-07-152022-10-31 Journal: Eurosurveillance [Category] COVID-19, SARS, [키워드] Asymptomatic asymptomatic infection contribute COVID-19 COVID-19 vaccine Effectiveness Infection investigated less public health recommendation SARS-CoV-2 SARS-COV-2 infection symptomatic symptomatic and asymptomatic systematic review Transmission vaccinated individuals vaccination vaccine effectiveness [DOI] 10.2807/1560-7917.ES.2021.26.28.2100563 PMC 바로가기 [Article Type] Rapid Communication
An outbreak caused by the SARS-CoV-2 Delta (B.1.617.2) variant in a care home after partial vaccination with a single dose of the COVID-19 vaccine Vaxzevria, London, England, April 20212021년 4월 영국 런던에서 COVID-19 백신 Vaxzevria의 단일 용량으로 부분 백신 접종을 한 후 요양원에서 SARS-CoV-2 Delta(B.1.617.2) 변종으로 인한 발병Rapid Communication Published on 2021-07-082022-09-10 Journal: Eurosurveillance [Category] SARS, 변종, [키워드] AstraZeneca attack rate B.1.617.2 B.1.617.2 variant Care care home outbreaks caused ChAdOx1 ChAdOx1 vaccine ChAdOx1-S COVID-19 COVID-19 outbreak COVID-19 vaccine Delta delta variant died England hospitalised individual investigated London outbreak SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 infections single dose the SARS-CoV-2 vaccination Vaccine vaccine dose vaccine effectiveness variant Vaxzevria [DOI] 10.2807/1560-7917.ES.2021.26.27.2100626 PMC 바로가기 [Article Type] Rapid Communication